Stay updated with breaking news from Microfluidic Modulation Spectroscopy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article presents a detailed investigation of Trastuzumab and its biosimilars, focusing on their structural integrity and stability.
This article highlights the superiority of Microfluidic Modulation Spectroscopy (MMS) over Circular Dichroism (CD) in detecting and characterizing structural changes in beta-sheet-rich proteins.
This article highlights RedShiftBio's MMS™ technology, detailing its effectiveness in proteintherapeutic analysis through enhanced sensitivity and dynamic range.
This article talks about the role of Microfluidic Modulation Spectroscopy to analyze MMP Structure.
/PRNewswire/ -- RedShift BioAnalytics (RedShiftBioⓇ) today announced it was launching the HaLCon Analyzer, an advanced, fit-for-purpose, liquid chromatography...